IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 202 filers reported holding IMMUNOGEN INC in Q4 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $54,000 | -21.7% | 15,000 | 0.0% | 0.02% | -25.0% |
| Q2 2020 | $69,000 | +35.3% | 15,000 | 0.0% | 0.02% | +26.3% |
| Q1 2020 | $51,000 | -33.8% | 15,000 | 0.0% | 0.02% | -26.9% |
| Q4 2019 | $77,000 | +113.9% | 15,000 | 0.0% | 0.03% | +100.0% |
| Q3 2019 | $36,000 | +9.1% | 15,000 | 0.0% | 0.01% | +8.3% |
| Q2 2019 | $33,000 | -19.5% | 15,000 | 0.0% | 0.01% | -20.0% |
| Q1 2019 | $41,000 | -43.1% | 15,000 | 0.0% | 0.02% | -50.0% |
| Q4 2018 | $72,000 | -49.3% | 15,000 | 0.0% | 0.03% | -47.4% |
| Q3 2018 | $142,000 | -2.7% | 15,000 | 0.0% | 0.06% | -9.5% |
| Q2 2018 | $146,000 | -7.6% | 15,000 | 0.0% | 0.06% | -8.7% |
| Q1 2018 | $158,000 | +64.6% | 15,000 | 0.0% | 0.07% | +64.3% |
| Q4 2017 | $96,000 | -16.5% | 15,000 | 0.0% | 0.04% | -19.2% |
| Q3 2017 | $115,000 | +7.5% | 15,000 | 0.0% | 0.05% | 0.0% |
| Q2 2017 | $107,000 | – | 15,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |